May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug in 20 years, when Edaravone/Radicava, developed by Japanese company MT Pharma, received orphan drug registration. Still, available therapies only slow down the progression of the …

This awesome article How Close Are We to Curing ALS? A Review of Biotech’s Efforts appeared first on Labiotech.eu. Be kind and don’t copy it without asking 😉



Source link

Read More